 STATEN ISLAND, N.Y. , Aug. 4, 2022 PRNewswire -- Acurx Pharmaceuticals, Inc. NASDAQ: ACXP Acurx or the Company, a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will release its 2022 second quarter financial results on Tuesday, August 16, 2022, at 8:30 am ET before the U.S. financial markets open. 